Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase II, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy of Partuzumab (rhuMAb 2C4) in Combination with Gencitabine
Ueland, Frederick
(PI)
Obstetrics and Gynecology
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
6/1/05
→
12/31/07
Funding
Genentech Inc:
$282,961.00
View all
View less